Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
BIIB compared with AMGN: revenue, margins and what each company keeps, and the suppliers and customers both name
BIIB
Biogen Inc.
Change
Mkt cap
Revenue
Revenue
AMGN
Amgen Inc
Change
Mkt cap
Revenue
Revenue
vs
Compare
BIIB
Biogen Inc.
vs
AMGN
Amgen Inc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
BIIB
Biogen Inc.
Change
253.65
· pre 248.97
· delayed
Mkt cap
$37.5B
Revenue
$2.8B
Q3 FY26
Revenue
$9.9B
FY25
AMGN
Amgen Inc
Change
465.45
· pre 463.50
· delayed
Pre-market
Nov 3 '26
delayed
Mkt cap
$251.6B
Revenue
$10.1B
Q2 FY26
Revenue
$36.8B
FY25
vs
Compare
Pre-market
Nov 3 '26
delayed
BIIB
Biogen Inc.
vs
AMGN
Amgen Inc
253.65
pre 248.97
delayed
Price
465.45
pre 463.50
delayed
$37.5B
Mkt cap
$251.6B
Q3 FY26
$2.8B
Revenue
$10.1B
Q2 FY26
FY25
$9.9B
Revenue
$36.8B
FY25
Change
Change
BIIB
253.65
vs
AMGN
465.45
Pre-market
Nov 3 '26
delayed
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only BIIB
18
ALKS
Alkermes
supplier
DNLI
Denali Therapeutics
supplier
KNSA
Kiniksa Pharmaceuticals International
customer
SUPN
Supernus Pharmaceuticals
supplier
14 more · BIIB chain
›
Shared
0
No shared counterparties.
Only AMGN
12
PODD
Insulet
supplier
CYTK
Cytokinetics
supplier
ARWR
Arrowhead Pharmaceuticals
supplier
LGND
Ligand Pharmaceuticals
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
8 more · AMGN chain
›